Bergen, Norway – University of Bergen researcher Markus Miettinen is among the first scientists to provide a detailed description of protein clumps associated with Huntington’s disease. The findings, which could pave the way for new diagnostic tools and treatments, were recently presented in an article in Nature Communications. “There is...
Latest News
Beijing, China – Imagine the deep frustration of countless men who long to become fathers, only to face infertility due to a genetic condition they can’t control. For those with Klinefelter syndrome, this painful reality is a constant struggle. How does an extra X chromosome lead to infertility in men? Professor...
Chicago, Illinois – Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Fifty-nine percent of patients responds so well to this therapy that adjuvant treatment is no longer needed, according to the results of the NADINA study that were published today. The NADINA study, led by...
Hinxton, England – Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery...
San Francisco, Calif. – Progressive supranuclear palsy (PSP), a mysterious and deadly neurological disorder, usually goes undiagnosed until after a patient dies and an autopsy is performed. But now, UC San Francisco researchers have found a way to identify the condition while patients are still alive. A study appearing in Neurology on...
MINNEAPOLIS/ST. PAUL, Minn. — For the first time, researchers at the University of Minnesota Twin Cities showed that non-invasive brain stimulation can change a specific brain mechanism that is directly related to human behavior. This is a major step forward for discovering new therapies to treat brain disorders such as...
BEER-SHEVA and TEL AVIV, Israel – Ben-Gurion University (BGU) of the Negev’s Prof. Gad Vatine and Tel Aviv University’s Dr. Avraham Ashkenazi are up and coming young principal investigators. Vatine is an expert in studying rare disorders using patient-specific stem cells, and Ashkenazi is an expert in tri-nucleotide repeat expansion...
London, UK – The phase 3 clinical trial, led by Professor Peter Szlosarek at Queen Mary and sponsored by Polaris Pharmaceuticals, has unveiled a breakthrough in the treatment of malignant pleural mesothelioma (MPM), a rare and often rapidly fatal form of cancer with limited therapeutic options. The ATOMIC-meso trial, a...
Oxford, UK – Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of Huntington’s Disease. This discovery opens up the possibility of studying the disease before its clinical onset and eventually stopping its progression. The study, published in Nature Metabolism, has shown for...
Beijing, China – Cancer, characterized by the development of abnormal cells that divide uncontrollably, is generally associated with significant disease burden and high death rates. However, advancements in cancer biology, diagnostics, and therapeutics have greatly improved the treatment outcomes of patients with cancer. In recent years, targeted anticancer therapies such...